National Asset Management, Inc. Amgen Inc Transaction History

National Asset Management, Inc.

$3.82 Billion
Q2 2024

A detailed history of National Asset Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, National Asset Management, Inc. holds 40,127 shares of AMGN stock, worth $11.2 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

40,127

Previous 43,207 7.13%

Holding current value

$11.2 Million

Previous $12.3 Million 2.06%

% of portfolio

0.33%

Previous 0.29%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 19, 2024	SELL	$262.75 - $319.31 $809,270 - $983,474	-3,080 Reduced 7.13%	40,127 $12.5 Million
Q1 2024 May 16, 2024	BUY	$268.87 - $324.56 $814,138 - $982,767	3,028 Added 7.54%	43,207 $12.3 Million
Q4 2023 Mar 15, 2024	SELL	$255.7 - $288.46 $774,259 - $873,456	-3,028 Reduced 7.01%	40,179 $11.6 Million
Q3 2023 Dec 01, 2023	SELL	$218.65 - $271.46 $12.4 Million - $15.4 Million	-56,581 Reduced 56.7%	43,207 $11.6 Million
Q2 2023 Jul 27, 2023	BUY	$214.27 - $253.37 $13.4 Million - $15.9 Million	62,634 Added 168.58%	99,788 $22.2 Million
Q1 2023 May 17, 2023	BUY	$225.79 - $275.2 $133,893 - $163,193	593 Added 1.62%	37,154 $8.98 Million
Q4 2022 Mar 15, 2023	SELL	$229.03 - $291.01 $7,557 - $9,603	-33 Reduced 0.09%	36,561 $9.6 Million
Q4 2022 Feb 21, 2023	SELL	$229.03 - $291.01 $1.27 Million - $1.62 Million	-5,560 Reduced 13.19%	36,594 $9.61 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $2.7 Million - $3.04 Million	12,016 Added 39.87%	42,154 $9.5 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $1.13 Million - $1.26 Million	4,904 Added 19.43%	30,138 $7.33 Million
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $361,356 - $399,755	1,648 Added 6.99%	25,234 $6.1 Million
Q4 2021 Jan 28, 2022	SELL	$198.88 - $227.6 $130,465 - $149,305	-656 Reduced 2.71%	23,586 $5.31 Million
Q3 2021 Nov 16, 2021	SELL	$212.27 - $248.7 $1.54 Million - $1.8 Million	-7,233 Reduced 22.98%	24,242 $5.16 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $450,575 - $499,881	1,929 Added 6.53%	31,475 $7.67 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $1.5 Million - $1.75 Million	6,776 Added 29.76%	29,546 $7.35 Million
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $1.93 Million - $2.3 Million	8,942 Added 64.67%	22,770 $5.24 Million
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $4,223 - $4,697	18 Added 0.13%	13,828 $3.52 Million
Q2 2020 Jul 31, 2020	BUY	$197.81 - $242.74 $1.07 Million - $1.31 Million	5,414 Added 64.48%	13,810 $3.26 Million
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $432,820 - $574,037	2,375 Added 39.45%	8,396 $1.71 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $44,085 - $56,665	-233 Reduced 3.73%	6,021 $1.45 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $35,170 - $42,141	-202 Reduced 3.13%	6,254 $1.21 Million
Q2 2019 Aug 05, 2019	BUY	$166.7 - $195.41 $92,185 - $108,061	553 Added 9.37%	6,456 $1.19 Million
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $177,795 - $200,414	-983 Reduced 14.28%	5,903 $1.12 Million
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $98,476 - $114,954	-552 Reduced 7.42%	6,886 $1.34 Million
Q3 2018 Nov 08, 2018	BUY	$185.29 - $208.89 $203,077 - $228,943	1,096 Added 17.28%	7,438 $1.54 Million
Q2 2018 Oct 05, 2018	BUY	$166.05 - $186.51 $92,157 - $103,513	555 Added 9.59%	6,342 $1.17 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $351,397 - $410,652	-2,074 Reduced 26.38%	5,787 $988,000
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $266,350 - $297,595	1,578 Added 25.12%	7,861 $1.37 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $123,292 - $140,767	737 Added 13.29%	6,283 $1.17 Million
Q2 2017 Aug 15, 2017	BUY	N/A	5,546	5,546 $957,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.

Account

National Asset Management, Inc. Amgen Inc Transaction History